A Muslim parent is suing a number of Texas officials, alleging they have categorically excluded Islamic private schools from ...

Nashville Electric Service bolstered its Critical Care Referral Program for customers who need electricity to power life-sustaining medical devices.

A Kansas City man has pleaded guilty in federal court to fraudulently obtaining nearly half a million dollars in COVID-19 relief funds through the Paycheck Protection Program.

FDA expanded zongertinib’s accelerated approval to treatment-naïve HER2-mutant advanced NSCLC, contingent on mutation ...

FDA assigns PDUFA target action date in the third quarter of calendar year 2026 with launch expected at the end of September 2026Priority Review supported by positive Phase 3 VALOR results, the first ...

As part of the recently enacted Consolidated Appropriations Act of 2026, Congress has reauthorized the Rare Pediatric Disease Priority Review Voucher (RPD PRV) program, long sought by the ...

Priority Ambulance and Columbia Southern University Announce Education Partnership to Expand Career Pathways for EMS Professionals ...

Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron · GlobeNewswire Inc. The Mikaela Naylon Give Kids a Chance Act reauthorizes the Pediatric Priority ...

New York, New York--(Newsfile Corp. - February 4, 2026) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, is ...

There is still time to apply for scholarship funding at Southern State for the 2026 Fall Semester/2027 Spring Semester. To keep the process simple, Southern State uses a single online application ...

In the two weeks since the application portal opened, more than 100,000 applicants filed for a slice of the $1 billion in the new Texas Education Freedom Accounts (TEFA) program.

Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval RPD designation is granted to drug candidates intended to treat ...